Biologics Manufacturing Asia 2020
Discover, discuss and debate on the best manufacturing practices to make better biologic drugs, cheaper and faster!Download Brochure
Asia Bioprocessing Excellence Awards 2020
Don't Forget To Nominate Your Company For The Awards!Nominate Here
Showcase Your Solutions!Sponsorship Prospectus
The biologics industry in Asia- Pacific is estimated to be the fastest growing market in the world. The key drivers motivating the growth of the biologics industry in Asia are competitive manufacturing costs, the increase in of high-skilled workers, new- cell culture techniques, fast-track flexible GMP facilities equipped with disposables, attempts for integrated continuous manufacturing, combining modular facilities, single-use and other advances in the downstream processing of biologics. While experiencing excellence in manufacturing processes, the industry is constantly reworking strategies and on the lookout for tools to overcome high-manufacturing complexities, expensive purification processes and other challenges across the bioprocessing value chain. Crucial aspects of process and product characterization, analytical method development amongst others support the manufacturing value chain and analytical technologies are being explored. Portfolios are expanding to include heavier emphasis on regenerative medicine, particularly cell and gene therapy.
To facilitate brainstorming, strategy-generating discussions on the aforementioned key aspects of the biologics industry, IMAPAC is bringing to you 3 focus areas: Bio-Manufacturing, Bio-Analytics and Cell Therapy Bioprocessing as part of Asia's biggest, most focussed annual bioprocessing conference, the 7th Annual Biologics Manufacturing Asia 2020!
The 7th Annual Biologics Manufacturing World Asia is the largest and ONLY bioprocess business and technology convention in Asia Pacific! In 2020, 500+ biomanufacturing stakeholders from BIG Pharma, Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities, Solution Providers across Singapore, South Korea, Taiwan, Japan, Australia, India, South East Asia, Indo China, and China will convene to discover, discuss and debate on the best manufacturing practices to make better biologic drugs cheaper and faster!
John Higgins Merck & Co.
Joydeep Ganguly Gilead Sciences
Ronan McGarvey Abbvie
Zhang Peiqing Hanzhou JUST Biotherapeutics
Behzad Mahdavi Lonza
Kendrick Chao PharmaEssentia
Neil McGowan BSc. (Hons.) PHD MRSB Scottish National Blood Transfusion Service
Shuichi Yamamoto Yamaguchi University Biomedical Engineering Center
Alois Jungbauer University of Life Science & Natural Resources
Yen Choo Progenitor Therapeutics
Seungsun Lee Samsung Biologics
Yong Jick Kim Polus Inc.
Cavin Jang Kolon Life Sciences
Yosuke Watanabe Chugai Pharmaceutical Co. Ltd
Ayano Fukuhara Osaka University
Meiyappan Lakshmanan A*Star
Gerald Striedner University of Natural Resources and Life Sciences
David Kim KitePharma
Takahashi Ryosuke Hitachi Chemical
Christoph Herwig TU Wien
Chris Sweeney PT Kalbe
2020 Silver Sponsor
2020 Media Partners
Leverage on this year’s best marketing and sales opportunity to access the fastest growing biologics market of the world! Biologics World Asia 2020 will be attended by decision-makers who will influence the future of Asia’s biologics industry. Your potential clients and partners are hungry for new biologics technologies and services, and they need you to make it happen. Be there and be seen!
eBook: Cell Therapy Manufacturing Facilities in Asia
eBook: Investment Landscape Asia Edition
Prof George Lovrecz Presentation
For any queries regarding venue or accommodation, please contact:
Si Hui Sim
Senior Operations Executive
T: +65 3109 0224